Cargando…
Virtual Double-System Single-Box: A Nonequilibrium Alchemical Technique for Absolute Binding Free Energy Calculations: Application to Ligands of the SARS-CoV-2 Main Protease
[Image: see text] In the context of drug–receptor binding affinity calculations using molecular dynamics techniques, we implemented a combination of Hamiltonian replica exchange (HREM) and a novel nonequilibrium alchemical methodology, called virtual double-system single-box, with increased accuracy...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015232/ https://www.ncbi.nlm.nih.gov/pubmed/33090785 http://dx.doi.org/10.1021/acs.jctc.0c00634 |
_version_ | 1783673639755841536 |
---|---|
author | Macchiagodena, Marina Pagliai, Marco Karrenbrock, Maurice Guarnieri, Guido Iannone, Francesco Procacci, Piero |
author_facet | Macchiagodena, Marina Pagliai, Marco Karrenbrock, Maurice Guarnieri, Guido Iannone, Francesco Procacci, Piero |
author_sort | Macchiagodena, Marina |
collection | PubMed |
description | [Image: see text] In the context of drug–receptor binding affinity calculations using molecular dynamics techniques, we implemented a combination of Hamiltonian replica exchange (HREM) and a novel nonequilibrium alchemical methodology, called virtual double-system single-box, with increased accuracy, precision, and efficiency with respect to the standard nonequilibrium approaches. The method has been applied for the determination of absolute binding free energies of 16 newly designed noncovalent ligands of the main protease (3CL(pro)) of SARS-CoV-2. The core structures of 3CL(pro) ligands were previously identified using a multimodal structure-based ligand design in combination with docking techniques. The calculated binding free energies for four additional ligands with known activity (either for SARS-CoV or SARS-CoV-2 main protease) are also reported. The nature of binding in the 3CL(pro) active site and the involved residues besides the CYS–HYS catalytic dyad have been thoroughly characterized by enhanced sampling simulations of the bound state. We have identified several noncongeneric compounds with predicted low micromolar activity for 3CL(pro) inhibition, which may constitute possible lead compounds for the development of antiviral agents in Covid-19 treatment. |
format | Online Article Text |
id | pubmed-8015232 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-80152322021-04-02 Virtual Double-System Single-Box: A Nonequilibrium Alchemical Technique for Absolute Binding Free Energy Calculations: Application to Ligands of the SARS-CoV-2 Main Protease Macchiagodena, Marina Pagliai, Marco Karrenbrock, Maurice Guarnieri, Guido Iannone, Francesco Procacci, Piero J Chem Theory Comput [Image: see text] In the context of drug–receptor binding affinity calculations using molecular dynamics techniques, we implemented a combination of Hamiltonian replica exchange (HREM) and a novel nonequilibrium alchemical methodology, called virtual double-system single-box, with increased accuracy, precision, and efficiency with respect to the standard nonequilibrium approaches. The method has been applied for the determination of absolute binding free energies of 16 newly designed noncovalent ligands of the main protease (3CL(pro)) of SARS-CoV-2. The core structures of 3CL(pro) ligands were previously identified using a multimodal structure-based ligand design in combination with docking techniques. The calculated binding free energies for four additional ligands with known activity (either for SARS-CoV or SARS-CoV-2 main protease) are also reported. The nature of binding in the 3CL(pro) active site and the involved residues besides the CYS–HYS catalytic dyad have been thoroughly characterized by enhanced sampling simulations of the bound state. We have identified several noncongeneric compounds with predicted low micromolar activity for 3CL(pro) inhibition, which may constitute possible lead compounds for the development of antiviral agents in Covid-19 treatment. American Chemical Society 2020-10-22 2020-11-10 /pmc/articles/PMC8015232/ /pubmed/33090785 http://dx.doi.org/10.1021/acs.jctc.0c00634 Text en © 2020 American Chemical Society Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Macchiagodena, Marina Pagliai, Marco Karrenbrock, Maurice Guarnieri, Guido Iannone, Francesco Procacci, Piero Virtual Double-System Single-Box: A Nonequilibrium Alchemical Technique for Absolute Binding Free Energy Calculations: Application to Ligands of the SARS-CoV-2 Main Protease |
title | Virtual Double-System Single-Box: A Nonequilibrium
Alchemical Technique for Absolute Binding Free Energy Calculations:
Application to Ligands of the SARS-CoV-2 Main Protease |
title_full | Virtual Double-System Single-Box: A Nonequilibrium
Alchemical Technique for Absolute Binding Free Energy Calculations:
Application to Ligands of the SARS-CoV-2 Main Protease |
title_fullStr | Virtual Double-System Single-Box: A Nonequilibrium
Alchemical Technique for Absolute Binding Free Energy Calculations:
Application to Ligands of the SARS-CoV-2 Main Protease |
title_full_unstemmed | Virtual Double-System Single-Box: A Nonequilibrium
Alchemical Technique for Absolute Binding Free Energy Calculations:
Application to Ligands of the SARS-CoV-2 Main Protease |
title_short | Virtual Double-System Single-Box: A Nonequilibrium
Alchemical Technique for Absolute Binding Free Energy Calculations:
Application to Ligands of the SARS-CoV-2 Main Protease |
title_sort | virtual double-system single-box: a nonequilibrium
alchemical technique for absolute binding free energy calculations:
application to ligands of the sars-cov-2 main protease |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015232/ https://www.ncbi.nlm.nih.gov/pubmed/33090785 http://dx.doi.org/10.1021/acs.jctc.0c00634 |
work_keys_str_mv | AT macchiagodenamarina virtualdoublesystemsingleboxanonequilibriumalchemicaltechniqueforabsolutebindingfreeenergycalculationsapplicationtoligandsofthesarscov2mainprotease AT pagliaimarco virtualdoublesystemsingleboxanonequilibriumalchemicaltechniqueforabsolutebindingfreeenergycalculationsapplicationtoligandsofthesarscov2mainprotease AT karrenbrockmaurice virtualdoublesystemsingleboxanonequilibriumalchemicaltechniqueforabsolutebindingfreeenergycalculationsapplicationtoligandsofthesarscov2mainprotease AT guarnieriguido virtualdoublesystemsingleboxanonequilibriumalchemicaltechniqueforabsolutebindingfreeenergycalculationsapplicationtoligandsofthesarscov2mainprotease AT iannonefrancesco virtualdoublesystemsingleboxanonequilibriumalchemicaltechniqueforabsolutebindingfreeenergycalculationsapplicationtoligandsofthesarscov2mainprotease AT procaccipiero virtualdoublesystemsingleboxanonequilibriumalchemicaltechniqueforabsolutebindingfreeenergycalculationsapplicationtoligandsofthesarscov2mainprotease |